Tango Therapeutics Inc
Biotechnology
Healthcare
TNGX
109 M shares
NASDAQ US
traded
09 Apr 2025
listed
no
open
1.17
52 week high
11.93
high
1.51
52 week low
1.37
low
1.11
growth
-81.25 %
previous Close
1.37
P/E ratio
market cap
335 M
div yield
0
usd
Sep 2024
qoq
revenue
11.61 M
-41.60 %
net incoming
-29.17 M
-14.15 %
eps
0.00 %
-12.50 %
eps surprise
27.03 %
net profit margin
-251.29 %
-122.00 %
operating incoming
-32.88 M
-11.25 %
net change in cash
1.58 M
116.48 %
cash on hand
53.15 M
3.07 %
cost of revenue
0.00 %
top top